Early short-term imatinib treatment is sufficient to prevent the development of chronic allograft nephropathy

Minna Johanna Savikko, Jukka M. Rintala, Sini E. Rintala, Petri K. Koskinen, Eva von Willebrand

Research output: Contribution to journalArticleScientificpeer-review

Original languageEnglish
JournalNephrology, Dialysis, Transplantation
Volume26
Issue number9
Pages (from-to)3026-U1600
Number of pages7
ISSN0931-0509
DOIs
Publication statusPublished - 2011
MoE publication typeA1 Journal article-refereed

Fields of Science

  • chronic allograft nephropathy
  • imatinib
  • kidney transplantation
  • platelet-derived growth factor
  • CHRONIC MYELOID-LEUKEMIA
  • RENAL-FAILURE SECONDARY
  • KINASE INHIBITOR STI571
  • GROWTH-FACTOR RECEPTORS
  • ABL TYROSINE KINASE
  • VERSUS-HOST-DISEASE
  • ACUTE REJECTION
  • MESYLATE TREATMENT
  • DYSFUNCTION
  • EXPRESSION
  • 3121 General medicine, internal medicine and other clinical medicine

Cite this